Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

Abstract Background This study aimed to propose a new user-friendly, cost effective and robust risk model to facilitate risk stratification for diffuse large B-cell lymphoma (DLBCL) treated with frontline R-CHOP regimens. Methods Data on 998 patients with de novo DLBCL diagnosed between Jan 1st, 200...

Full description

Bibliographic Details
Main Authors: Haizhu Chen, Qiaofeng Zhong, Yu Zhou, Yan Qin, Jianliang Yang, Peng Liu, Xiaohui He, Shengyu Zhou, Changgong Zhang, Lin Gui, Sheng Yang, Liqiang Zhou, Yuankai Shi
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Diffuse large B-cell lymphoma
β2-microglobulin
Platelet count
Red blood cell distribution width
Prognosis
International prognostic index
Online Access:https://doi.org/10.1186/s12885-022-09693-z

Internet

https://doi.org/10.1186/s12885-022-09693-z

Similar Items